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Introduction: Pituicytoma is a rare neoplasm of the neurohypophysis. To the best of our knowledge there have
been no reports of pituicytoma in which long-term magnetic resonance imaging observation was performed. We
calculated the doubling time of the tumor volume and described the growth pattern of a pituicytoma.
Case presentation: A 52-year-old Japanese man with a history of decreased libido was found to have a sellar and
suprasellar mass. He underwent transsphenoidal surgery, but only a small specimen was obtained because of
intraoperative bleeding. The tentative histological diagnosis was schwannoma. He noticed bitemporal hemianopsia
7 years later. A follow-up magnetic resonance imaging disclosed a tumor volume doubling time of 3830 days.
Transcranial gross-total tumor resection was performed. The lesion consisted of elongated and plump tumor cells
that were arranged in a fascicular or storiform pattern and were positive for S-100 protein and focally positive for
glial fibrillary acidic protein. The final histological diagnosis was pituicytoma.
Conclusion: Pituicytoma is a slow-growing tumor, but the growth rate may change during follow-up.
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Pituicytoma is a rare neoplasm in adults. It corresponds
to a low-grade astrocytoma of the neurohypophysis that
presumably arises from pituicytes of the stalk and pos-
terior lobe of the pituitary gland [1,2]. This tumor is
included in the 2007 World Health Organization
(WHO) classification of tumors of the central nervous
system as a WHO grade 1 tumor [3]. We report a case
of pituicytoma and discuss the neuroimaging character-
istics and surgical findings.Case presentation
A 52-year-old Japanese man presented with a 1-year his-
tory of decreased libido. He was referred to our institu-
tion for evaluation of a possible pituitary tumor.
Laboratory tests were all within normal limits except for
a low free testosterone level. A visual field defect in his
upper right quadrant was found in a neuro-ophthalmologic* Correspondence: kosugeyasushi@marianna-u.ac.jp
Department of Neurosurgery, St. Marianna University School of Medicine,
2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan
© 2012 Kosuge et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orexamination. Magnetic resonance imaging (MRI) revealed a
20mm mass that was isointense on T1-weighted MRI and
hyperintense on T2-weighted MRI. The lesion was
homogeneously enhanced with gadolinium (Figure 1).
Computed tomography (CT) scans showed strong contrast
enhancement.
Transsphenoidal tumor removal was attempted, but
only a small specimen was obtained because control of
tumor bleeding was difficult. Hematoxylin-eosin staining
revealed spindle cells with an eosinophilic cytoplasm.
On immunohistochemical staining, the tumor cells were
positive for S-100 protein, but negative for glial fibrillary
acidic protein (GFAP) and cytokeratin. The patient’s mo-
lecular immunology Borstel-1 (MIB-1) proliferation
index was less than 2%. The tentative histological diag-
nosis was schwannoma. Hydrocortisone and levothyrox-
ine sodium hydrate were administered postoperatively.
The visual field testing did not show any change from
his preoperative testing. We recommended a second
transcranial surgery or radiotherapy, but the patient
refused both proposed treatments. Therefore, careful ob-
servation has subsequently been performed with yearlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Initial magnetic resonance imaging. A) T1-weighted magnetic resonance image showing an isointense pituitary mass.
B) T2-weighted magnetic resonance image showing a hyperintense mass.
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in the first 5 years after surgery, with a tumor volume
doubling time (TVDT) of 20,267 days. Progressive
bitemporal hemianopsia occurred at 7 years after surgery
and MRI revealed apparent tumor progression during
the previous 2 years (Figure 2). The TVDT during these
2 years was 1369 days and the overall TVDT over 7
years was 3830 days.
The patient finally decided to undergo surgery to re-
move the tumor. A second operation was performed for
transcranial tumor removal with an interhemispheric ap-
proach. The tumor was soft and hemostasis of tumor
bleeding was difficult. The surgical removal was gross
total. The postoperative course was uneventful except
for transient diabetes insipidus. Clinical examination
showed an improvement of visual field defects. There
has been no recurrence for 1 year postoperatively. Histo-
logically, elongated and plump tumor cells were
arranged in a fascicular or storiform pattern and con-
tained eosinophilic cytoplasm. Immunohistochemical
stains were positive for S-100 protein and vimentin, fo-
cally positive for GFAP, and negative for synaptophysin,
epithelial membrane antigen (EMA), and periodic acid-
Schiff (PAS). The patient’s MIB-1 index was 1% (Figure 3).
All these findings are compatible with a diagnosis of
pituicytoma.
Discussion
Pituicytoma is a very rare tumor of the adult neurohyp-
ophysis with only about 50 reported cases [4]. SeveralFigure 2 Magnetic resonance imaging at 7 years after initial surgery.
resonance image showing enlargement of the tumor.authors have also used the term ‘pituicytoma’ to refer to
other tumors in the neurohypophysis, especially pilocytic
astrocytoma and granular cell tumor. The 2007 WHO
classification of tumors of the central nervous system
defines pituicytoma as a low-grade glial neoplasm of the
neurohypophysis or infundibulum that originates from
pituicytes [3].
The neuroimaging characteristics of pituicytomas are
nonspecific. Pituicytomas have been described to be
located within the sellar, the suprasellar region or both
[4]. Although there were not many reports on the CT
findings of pituicytomas, in the case reported by Wolfe
et al. [2], the tumor showed sellar enlargement and bony
remodeling on CT scan. MRI shows an isointense mass
on T1-weighted images, hyperintensity on T2-weighted
images, and homogeneous enhancement with gadolin-
ium. Therefore, the radiological differential diagnosis
should include other sellar or suprasellar tumors includ-
ing meningioma, craniopharyngioma, hemangiopericy-
toma, granular cell tumor, and pilocytic astrocytoma [4].
It is often difficult to identify these tumors in preopera-
tive neuroradiological findings, especially for nonfunc-
tioning pituitary adenoma in our case. However, the
histologic appearance and immunohistochemical find-
ings are distinctive [2,3]. Pituicytomas contain elongated
spindle cells that are arranged in a bundle or storiform
pattern with no granular component. Staining is positive
for S-100, focally positive for GFAP and EMA, and nega-
tive for PAS. In the current case, we believe that the
resected specimen in the first surgery stained negativelyA–C) Axial, coronal and sagittal contrast-enhanced magnetic
Figure 3 Microscopic findings. A) Microphotograph of an hematoxylin and eosin-stained section showing bipolar spindle cells arranged in a
storiform pattern. B) S-100 immunohistochemical stain. C,D) Immunohistochemical stains were focally positive for glial fibrillary acidic protein and
positive for vimentin.
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possible in this surgery.
In previous reports, the most common symptoms at
presentation of pituicytoma have been headache (38.9%)
followed by visual field defect (31.5%). Only one patient
presented with diabetes insipidus, despite pituicytomas
arising from the posterior pituitary gland or infundibu-
lum [4]. Nakasu et al. suggested that pituicytomas start
to grow in the posterior lobe or lower portion of the
stalk, so the upper neurohypophysis might have to com-
pensate for the loss of function [5].Figure 4 A semi-logarithmic graph showing serial changes of the tum
during the follow-up period of 7 years, with TVDTs of 20267 days over theSurgery is the main treatment for pituicytoma [6].
Tumor recurrence has occurred in some patients after
subtotal resection, but there have been no reports of re-
currence or enlargement in patients who underwent
total or gross total resection [1,5]. Thus, the best chance
for cure appears to be gross total resection because par-
tial resection carries a significant possibility of recur-
rence [2]. In our first surgery, we were able to achieve
only a biopsy because of significant bleeding. Several
other reports have also described considerable bleeding
during surgery [1-3,5-14], whereas others have indicatedor volume. The tumor volume doubling time (TVDT) was 3830 days
first 5 years and 1369 days over the last 2 years.
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the tumor size for these two types, based on definition
of the sagittal diameter of the pons as 26.6mm [15] and
estimation of the tumor size from sagittal MRI. The
mean diameter did not differ significantly between
hemorrhagic tumors (22.9mm) and non-hemorrhagic
tumors (21.4mm). Therefore, the risk of intraoperative
bleeding does not seem to depend on the tumor size.
Some patients who underwent subtotal resection were
also treated with postoperative radiotherapy [1,7,8].
However, the value of adjuvant therapy for pituicytomas
is anecdotal and unclear in the absence of evidence from
a large series [2,6].
The natural history of pituicytomas is unknown [6].
We performed MRI follow-up for 81 months after bi-
opsy and measured sequential changes in the tumor
volume (Figure 4), which was computed by summing
the tumor areas of all slices and multiplying by the slice
thickness. This permits evaluation of the natural pro-
gression of pituicytoma, and to the best of our know-
ledge this is the first report of the growth pattern of a
pituicytoma. The TVDT over 7 years was 3830 days, in-
cluding a period of very slow growth in the first 5 years,
during which the TVDT was 20,267 days. The tumor
then rapidly enlarged, with a TVDT of 1369 days over
the last 2 years. It is unclear why the growth rate chan-
ged during the postoperative course, but surgery might
have been an influential factor. There is also a possibility
that pituicytomas may enlarge rapidly without malignant
change. The relatively slow growth of pituicytomas and
the possible change in growth rate during follow-up
should be recognized in determining the most appropri-
ate treatment approach, although accumulation of more
cases is necessary to confirm these findings.Conclusions
Pituicytoma is an extremely rare tumor of the neurohyp-
ophysis. To the best of our knowledge this is the first
report of the TVDT of pituicytoma. Pituicytoma is a
slow-growing tumor, but may enlarge rapidly without
malignant change. The relatively slow growth of pituicy-
toma and the possible change in growth rate during fol-
low up should be recognized in determining the most
appropriate treatment approach.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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